<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03577548</url>
  </required_header>
  <id_info>
    <org_study_id>P/2016/290</org_study_id>
    <nct_id>NCT03577548</nct_id>
  </id_info>
  <brief_title>Influence of Main Psychological and Social Factors on Primary Headaches</brief_title>
  <acronym>CEPHAPSY</acronym>
  <official_title>Influence of Main Psychological and Social Factors on Primary Headaches</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to describe the psychological and social characteristics of patients
      suffering from primary headache and monitored in Neurology department of Besançon University
      Hospital
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of our study is to describe the psychological patterns in a population of patients
      suffering of episodic migraine or chronic migraine with and without medication overuse and
      the level of disability.

      Data about migraine characteristics will be obtained using a standardized questionnaire.

      Socio-demographic data will be obtained for all patients including gender, age, educational
      level and professional status.

      A booklet of 10 self-administered questionnaires will permit to measure psychological factors
      such as depression, anxiety, alexithymia...
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">May 2, 2016</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Descriptive analysis of socio-demographic questionnaire</measure>
    <time_frame>Day 1</time_frame>
    <description>Composite outcome assessed with 10 questionnaires are submitted to the patients and all their results are combined in order to identify psychological and social characteristics of the patients:
Quantitative variables will be mean, standard deviation, median and minimal/maximal values. Qualitative variables will be described by frequency and proportion of each class.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Descriptive analysis of Short Form 36 (SF 36) Health Survey</measure>
    <time_frame>Day 1</time_frame>
    <description>Composite outcome assessed with 10 questionnaires are submitted to the patients and all their results are combined in order to identify psychological and social characteristics of the patients:
Quantitative variables will be mean, standard deviation, median and minimal/maximal values. Qualitative variables will be described by frequency and proportion of each class.
This questionnaire asseses quality of life.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Descriptive analysis of General Health Questionnaire 12</measure>
    <time_frame>Day 1</time_frame>
    <description>Composite outcome assessed with 10 questionnaires are submitted to the patients and all their results are combined in order to identify psychological and social characteristics of the patients:
Quantitative variables will be mean, standard deviation, median and minimal/maximal values. Qualitative variables will be described by frequency and proportion of each class.
Ranges for this questionnaire: 0 - 1 : no psychological distress / 2 - 3 : psychological problems / 4 - 48 : suspicion of mental illness.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Descriptive analysis of Cungi test</measure>
    <time_frame>Day 1</time_frame>
    <description>Composite outcome assessed with 10 questionnaires are submitted to the patients and all their results are combined in order to identify psychological and social characteristics of the patients:
Quantitative variables will be mean, standard deviation, median and minimal/maximal values. Qualitative variables will be described by frequency and proportion of each class.
Ranges for this questionnaire: 12 - 19 : very low level of stress / 20 - 30 : low level of stress / 31 - 45 : high level of stress / &gt; 45 : very high level of stress.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Descriptive analysis of State-Trait Anxiety Inventory Y-A</measure>
    <time_frame>Day 1</time_frame>
    <description>Composite outcome assessed with 10 questionnaires are submitted to the patients and all their results are combined in order to identify psychological and social characteristics of the patients:
Quantitative variables will be mean, standard deviation, median and minimal/maximal values. Qualitative variables will be described by frequency and proportion of each class.
Ranges for this questionnaire (current anxiety): &lt; 36 : very low / 36 à 45 : low / 46 à 55 : medium / 56 à 65 : high / &gt; 65 : very high.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Descriptive analysis of State-Trait Anxiety Inventory Y-B</measure>
    <time_frame>Day 1</time_frame>
    <description>Composite outcome assessed with 10 questionnaires are submitted to the patients and all their results are combined in order to identify psychological and social characteristics of the patients:
Quantitative variables will be mean, standard deviation, median and minimal/maximal values. Qualitative variables will be described by frequency and proportion of each class.
Ranges for this questionnaire (general anxiety): &lt; 36 : very low / 36 à 45 : low / 46 à 55 : medium / 56 à 65 : high / &gt; 65 : very high.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Descriptive analysis of Beck Depression Inventory</measure>
    <time_frame>Day 1</time_frame>
    <description>Composite outcome assessed with 10 questionnaires are submitted to the patients and all their results are combined in order to identify psychological and social characteristics of the patients:
Quantitative variables will be mean, standard deviation, median and minimal/maximal values. Qualitative variables will be described by frequency and proportion of each class.
Ranges for this questionnaire: 0 - 4 : no depression / 5 - 7 : mild depression / 8 - 15 : moderate depression / &gt; 15 : severe depression.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Descriptive analysis of Social Support Questionnaire 6</measure>
    <time_frame>Day 1</time_frame>
    <description>Composite outcome assessed with 10 questionnaires are submitted to the patients and all their results are combined in order to identify psychological and social characteristics of the patients:
Quantitative variables will be mean, standard deviation, median and minimal/maximal values. Qualitative variables will be described by frequency and proportion of each class.
This questionnaire assesses satisfaction upon social support.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Descriptive analysis of Toronto Alexithymia Scale 20</measure>
    <time_frame>Day 1</time_frame>
    <description>Composite outcome assessed with 10 questionnaires are submitted to the patients and all their results are combined in order to identify psychological and social characteristics of the patients:
Quantitative variables will be mean, standard deviation, median and minimal/maximal values. Qualitative variables will be described by frequency and proportion of each class.
Three levels for alexythimia: &lt; 44 : non-alexithymia / 44 à 55 : possible alexithymia / &gt; 55 : alexithymia.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Descriptive analysis of Bartholomew Relationship Scales Questionnaire</measure>
    <time_frame>Day 1</time_frame>
    <description>Composite outcome assessed with 10 questionnaires are submitted to the patients and all their results are combined in order to identify psychological and social characteristics of the patients:
Quantitative variables will be mean, standard deviation, median and minimal/maximal values. Qualitative variables will be described by frequency and proportion of each class.
Four levels for this questionnaire: Secure, Preoccupied, Dismissing and Fearful.</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Headache, Migraine</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Auto- questionnaires</intervention_name>
    <description>10 auto-questionnaires are submitted to the patient during his/her consultation (which is part of the standard care).</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All subjects are suffering from primary headache and come for come for a specialized
        consultation in the Neurology department of Besançon University Hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients from 25 to 60 ans y.o suffering from primary headache and monitored in the
             Neurology department of Besançon University Hospital

        Exclusion Criteria:

          -  Patients with former or current psychic troubles
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rose-Angélique BELOT</last_name>
    <email>rose-angelique.belot@univ-fcomte.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Margaux BOUTELOUP</last_name>
    <email>margaux.bouteloup@live.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rose-Angélique BELOT</last_name>
      <email>rose-angelique.belot@univ-fcomte.fr</email>
    </contact>
    <contact_backup>
      <last_name>Margaux BOUTELOUP</last_name>
      <email>margaux.bouteloup@live.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Fabrice VUILLIER, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>March 26, 2018</study_first_submitted>
  <study_first_submitted_qc>July 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2018</study_first_posted>
  <last_update_submitted>July 3, 2018</last_update_submitted>
  <last_update_submitted_qc>July 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

